Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Read More…
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
Phone801-345-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.68 billion
Profitability
Miscellaneous
Employees4,900
Next Earnings Date8/1/2019 (Estimated)
OptionableOptionable
Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions
What is Nu Skin Enterprises' stock symbol?
Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."
How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?
Nu Skin Enterprises announced a quarterly dividend on Wednesday, May 1st. Stockholders of record on Friday, May 31st will be given a dividend of $0.37 per share on Wednesday, June 12th. This represents a $1.48 annualized dividend and a dividend yield of 3.03%. The ex-dividend date of this dividend is Thursday, May 30th. View Nu Skin Enterprises' Dividend History.
How were Nu Skin Enterprises' earnings last quarter?
Nu Skin Enterprises, Inc. (NYSE:NUS) posted its quarterly earnings results on Tuesday, April, 30th. The company reported $0.77 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.71 by $0.06. The company had revenue of $623.60 million for the quarter, compared to analysts' expectations of $615.98 million. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. The business's revenue was up 1.2% compared to the same quarter last year. During the same period last year, the firm earned $0.79 EPS. View Nu Skin Enterprises' Earnings History.
When is Nu Skin Enterprises' next earnings date?
What guidance has Nu Skin Enterprises issued on next quarter's earnings?
Nu Skin Enterprises issued an update on its FY19 earnings guidance on Tuesday, April, 30th. The company provided EPS guidance of $3.80-4.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.89. The company issued revenue guidance of $2.76-2.81 billion, compared to the consensus revenue estimate of $2.77 billion.Nu Skin Enterprises also updated its Q2 guidance to $0.91-0.98 EPS.
What price target have analysts set for NUS?
8 brokerages have issued 12 month target prices for Nu Skin Enterprises' stock. Their forecasts range from $43.00 to $92.00. On average, they expect Nu Skin Enterprises' share price to reach $72.8571 in the next twelve months. This suggests a possible upside of 49.1% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.
What is the consensus analysts' recommendation for Nu Skin Enterprises?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 sell ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nu Skin Enterprises.
What are Wall Street analysts saying about Nu Skin Enterprises stock?
Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
- 1. According to Zacks Investment Research, "Nu Skin, which has outdone the industry in the past month, has been steadily gaining from solid performance across most regional units and sustained growth in customer count. These upsides and enhanced margins fueled first-quarter 2019 results, wherein top and bottom lines grew year over year and surpassed estimates. Further, the company’s focus on expanding global beauty device systems and optimizing the Velocity program bodes well. This is reflected in management’s outlook for 2019. However, the company issued a soft view for the second quarter, which is likely to be hurt by tough year-over-year comparisons related to LumiSpa. Moreover, currency headwinds are expected to persist, and hurt sales growth by 4-5% and 2-3% in the second quarter and 2019, respectively. Competition from cheaper alternatives is certainly a threat as well." (5/3/2019)
- 2. Pivotal Research analysts commented, "We do expect share repurchase to accelerate and contribute meaningfully to 2019 and 2020. In 2018 diluted shares rose 2.3% compared to -2% in 2017; and -4.9% in 2016. NUS loves to shrink its share count. We think 2019 might be bigger than usual which is not in the guidance. We find the multi-year prospects for NUS shares to be excellent. Top line growth and expanding EBIT margins, accelerating share repurchases and a tax rate that may drift lower sets the stage for double-digit gains in EPS for many years. Management is excellent and improving the speed to market and technology of the business. It really is a near-perfect setup." (2/13/2019)
Has Nu Skin Enterprises been receiving favorable news coverage?
News headlines about NUS stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nu Skin Enterprises earned a news impact score of 1.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Nu Skin Enterprises.
Are investors shorting Nu Skin Enterprises?
Nu Skin Enterprises saw a decrease in short interest in May. As of May 31st, there was short interest totalling 1,513,800 shares, a decrease of 12.0% from the April 30th total of 1,720,500 shares. Based on an average trading volume of 755,600 shares, the days-to-cover ratio is currently 2.0 days. Currently, 2.9% of the company's stock are sold short. View Nu Skin Enterprises' Current Options Chain.
Who are some of Nu Skin Enterprises' key competitors?
What other stocks do shareholders of Nu Skin Enterprises own?
Who are Nu Skin Enterprises' key executives?
Nu Skin Enterprises' management team includes the folowing people:
- Mr. Steven J. Lund, Exec. Chairman (Age 66)
- Mr. Ritch N. Wood, CEO & Director (Age 53)
- Mr. Ryan S. Napierski, Pres (Age 45)
- Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)
- Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66)
Who are Nu Skin Enterprises' major shareholders?
Nu Skin Enterprises' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.54%), AJO LP (2.55%), William Blair Investment Management LLC (2.29%), Acadian Asset Management LLC (1.11%), Los Angeles Capital Management & Equity Research Inc. (0.98%) and Delek Group Ltd. (0.68%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Daniel W Campbell, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.
Which institutional investors are selling Nu Skin Enterprises stock?
NUS stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., MERIAN GLOBAL INVESTORS UK Ltd, First Trust Advisors LP, First Trust Advisors LP, Robeco Institutional Asset Management B.V., Bank of Montreal Can, AJO LP and Janus Henderson Group PLC. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Edwina D Woodbury, Joseph Y Chang and Ryan S Napierski. View Insider Buying and Selling for Nu Skin Enterprises.
Which institutional investors are buying Nu Skin Enterprises stock?
NUS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Delek Group Ltd., Federated Investors Inc. PA, Acadian Asset Management LLC, Prescott Group Capital Management L.L.C., Handelsbanken Fonder AB, Los Angeles Capital Management & Equity Research Inc. and Assenagon Asset Management S.A.. View Insider Buying and Selling for Nu Skin Enterprises.
How do I buy shares of Nu Skin Enterprises?
Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nu Skin Enterprises' stock price today?
One share of NUS stock can currently be purchased for approximately $48.87.
How big of a company is Nu Skin Enterprises?
Nu Skin Enterprises has a market capitalization of $2.71 billion and generates $2.68 billion in revenue each year. The company earns $121.88 million in net income (profit) each year or $3.52 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.View Additional Information About Nu Skin Enterprises.
What is Nu Skin Enterprises' official website?
How can I contact Nu Skin Enterprises?
Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at investorrel[email protected]
MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
